Submission for OMB Review; Comment Request; National Network of Tobacco Cessation Quitlines Evaluation, 51626-51627 [E6-14354]
Download as PDF
<![CDATA[
51626
Federal Register / Vol. 71, No. 168 / Wednesday, August 30, 2006 / Notices
Data are collected on the number of
full-time equivalent residents in
applicant children’s hospitals’ training
programs to determine the amount of
direct and indirect medical education
payments to be distributed to
participating children’s hospitals.
Indirect medical education payments
99–1
99–1
99–2
99–2
99–3
99–3
99–4
99–5
99–5
Responses
per
respondent
Number of
respondents
Form
HRSA
HRSA
HRSA
HRSA
HRSA
HRSA
HRSA
HRSA
HRSA
of full-time equivalent residents a
second time during the Federal fiscal
year to participate in the reconciliation
payment process.
The estimated annual burden is as
follows:
will also be derived from a formula that
requires the reporting of discharges,
beds, and case mix index information
from participating children’s hospitals.
Hospitals will be requested to submit
such information in an annual
application. Hospitals will also be
requested to submit data on the number
Total number
of
responses
(Initial Application) .........................................
(Reconciliation Application) ...........................
(Initial Application) .........................................
(Reconciliation Application) ...........................
(Initial Application) .........................................
(Reconciliation Application) ...........................
(Reconciliation Application) ...........................
(Initial Application) .........................................
(Reconciliation Application) ...........................
60
60
60
60
60
60
60
60
60
1
1
1
1
1
1
1
1
1
60
60
60
60
60
60
60
60
60
Total ............................................................................
60
........................
60
Send comments to Susan G. Queen,
Ph.D., HRSA Reports Clearance Officer,
Room 10–33, Parklawn Building, 5600
Fishers Lane, Rockville, MD 20857.
Written comments should be received
within 60 days of this notice.
Dated: August 23, 2006.
Cheryl R. Dammons,
Director, Division of Policy Review and
Coordination.
[FR Doc. E6–14411 Filed 8–29–06; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review;
Comment Request; National Network
of Tobacco Cessation Quitlines
Evaluation
jlentini on PROD1PC65 with NOTICES
Hours per
response
Summary: Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Cancer Institute, the National Institutes
of Health has submitted to the Office of
Management and Budget (OMB) a
request to review and approve the
information collection listed below.
This proposed information collection
was previously published in the Federal
Register on January 27, 2006 (page
4595) and allowed 60 days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment. The National Institutes of
Health may not conduct or sponsor, and
the respondent is not required to
respond to, an information collection
that has been extended, revised, or
VerDate Aug<31>2005
16:39 Aug 29, 2006
Jkt 208001
implemented on or after October 1,
1995, unless it displays a currently valid
OMB control number.
Proposed Collection
Title: Evaluation of the HHS National
Network of Tobacco Cessation Quitlines
Initiative.
Type of Information Collection
Request: New.
Need and Use of Information
Collection: In February 2004, the U.S.
Department of Health and Human
Services announced plans for a national
network of tobacco cessation quitlines
to provide all smokers in the United
States access to the support and latest
information to help them quit. To
provide the highest level of assistance to
smokers across the country who wants
to quit, NCI established a new toll-free
telephone number (1–800–QUIT–NOW)
on November 8, 2004. The aim of the
National Network of Tobacco Cessation
Quitlines (NNTCQ) initiative (the
Initiative) is to strengthen service
delivery; provide a mechanism for
integration and implementation of state,
regional, and national campaigns; and
increase healthcare utilization by
minority and medically underserved
populations. NCI, CDC, and other state,
private industry, and partner
organizations (the North American
Quitline Consortium) have created the
infrastructure and a coordinated
mechanism to offer cessation services to
the American public. The Initiative
seeks to enhance existing state-managed
quitlines and to encourage the
establishment of quitlines in states
without them. It is expected that
successful implementation of the
Initiative will foster partnerships across
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Total burden
hours
26
8
15
5
.25
.25
1,560
480
900
300
15
15
840
15
15
..........................
4,140
.25
.25
14
state quitlines for technology transfer,
sharing of effective practices, and
understanding patterns of use and reach
to special populations, thereby ensuring
a sustained level of effectiveness over
time. The goal of this evaluation is to
monitor the implementation of the
Initiative, assess its impact on key
stakeholders, and examine its
implications for public health. To that
end, this study will conduct a series of
in-depth key informant telephone
interviews and selected site visits with
state tobacco control officers, quitline
administrators and counseling staff.
Representatives of organizations and
individuals that partner with quitlines,
such as community health organizations
or health care providers, will also be
interviewed. The findings will provide
valuable information concerning the
development and implementation of the
NNTQC initiative as a potential model
for Federal-State partnerships, the
impact on building and enhancing state
quitline capacity, and implications for
the state tobacco control community.
The annual reporting burden is
presented in exhibit 1, below.
Frequency of Response: One occasion.
Affected Public: State agencies,
businesses or other for-profit, non-profit
associations.
Type of Respondents: Federal and
state employees, health services
providers, administrators and
researchers.
The annual reporting burden is as
follows:
Estimated Number of Respondents:
228.
Estimated Number of Responses per
Respondent: 1.
E:\FR\FM\30AUN1.SGM
30AUN1
51627
Federal Register / Vol. 71, No. 168 / Wednesday, August 30, 2006 / Notices
Average Burden Hours per Response:
.7445.
Estimated Total Annual Burden
Hours Requested: 169.75.
The annualized cost to respondents is
$7,129.50.
There are no Capital Costs to report.
There are no Operating or Maintenance
Costs to report.
Estimated
number of respondents
Estimated
number of
responses per
respondent
State Tobacco Control Manager .....................................................................
State Quitline Administrator .............................................................................
State Quitline Service Provider .......................................................................
State Quitline Partner ......................................................................................
NAQC Representative .....................................................................................
51
51
19
102
5
1
1
1
1
1
1.00
1.00
.75
.50
.50
51.00
51.00
14.25
51.00
2.50
Total ..........................................................................................................
228
........................
........................
169.75
jlentini on PROD1PC65 with NOTICES
Type of respondents
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information, including the validity of
the methodology and assumptions used;
(3) ways to enhance the quality, utility,
and clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, New Executive
Office Building, Room 10235,
Washington, DC 20503, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact Candace
Deaton, M.P.A., Project Officer, National
Cancer Institute, Cancer Information
Service, 6116 Executive Blvd., Suite
3056A, Room 3028, Rockville, MD
20892 or call non-toll-free number 301–
594–9072 or e-mail your request,
including your address to:
deatonc@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
VerDate Aug<31>2005
16:39 Aug 29, 2006
Jkt 208001
Dated: August 21, 2006.
Rachelle Ragland Greene,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. E6–14354 Filed 8–29–06; 8:45 am]
BILLING CODE 4101–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
ADDRESSES: Licensing information and
copies of the U.S. patent applications
listed below may be obtained by writing
to the indicated licensing contact at the
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301/
496–7057; fax: 301/402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
ABCB1 Genotyping To Predict
Paclitaxel Toxicity
Description of Technology: Paclitaxel
has been a frontline chemotherapeutic
drug used for the treatment of various
cancers including metastatic breast
cancer and ovarian cancer. Its use has
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Average
burden hours
per response
Estimated total
annual burden
hours
requested
successfully prolonged patient survival.
A major drawback of paclitaxel is the
cytotoxic side-effects that are associated
with it such as myologenic and
neurogenic toxicities. The degree of
such toxicities varies with individual
patients. Predicting the extent of such
toxicities following paclitaxel treatment
will immensely help in defining optimal
treatment schedules for each individual
patient. Concurrently, it will
significantly improve patient quality of
life.
This technology describes the
identification of three genetic markers
in the ABCB1 (MDR–1, P-glycoprotein)
gene that can be used to predict the
degree of neutropenia and peripheral
neuropathy that an individual will
experience following paclitaxel
treatment. These markers were
identified using DNA from blood
samples of cancer patients undergoing
paclitaxel treatment. This technology
can be developed into a routine blood
test to identify patient subsets that are
more susceptible to paclitaxel treatment
associated neutropenia and neuropathy.
Applications:
1. Three novel genetic markers that
can predict extent of paclitaxel
associated toxicities.
2. A screening test based on ABCB1
genotype profiling using patient blood
samples that predicts paclitaxel
associated neutropenia and peripheral
neuropathy.
Market: The diagnostic market is
worth about $3 billion by 2007 and
estimated to grow further.
Development Status:
1. The technology is a pilot study
currently in the pre-clinical stage of
development.
2. A prospective ABCB1 genotype
directed clinical trial is foreseen in the
near future.
Inventors: William D. Figg (NCI), Alex
Sparreboom (NCI), Tristan M. Sissung
(NCI), Stephan Mielke (NCI), et al.
E:\FR\FM\30AUN1.SGM
30AUN1
]]>Agencies
[Federal Register Volume 71, Number 168 (Wednesday, August 30, 2006)]
[Notices]
[Pages 51626-51627]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-14354]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; Comment Request; National Network of
Tobacco Cessation Quitlines Evaluation
Summary: Under the provisions of Section 3507(a)(1)(D) of the
Paperwork Reduction Act of 1995, the National Cancer Institute, the
National Institutes of Health has submitted to the Office of Management
and Budget (OMB) a request to review and approve the information
collection listed below. This proposed information collection was
previously published in the Federal Register on January 27, 2006 (page
4595) and allowed 60 days for public comment. No public comments were
received. The purpose of this notice is to allow an additional 30 days
for public comment. The National Institutes of Health may not conduct
or sponsor, and the respondent is not required to respond to, an
information collection that has been extended, revised, or implemented
on or after October 1, 1995, unless it displays a currently valid OMB
control number.
Proposed Collection
Title: Evaluation of the HHS National Network of Tobacco Cessation
Quitlines Initiative.
Type of Information Collection Request: New.
Need and Use of Information Collection: In February 2004, the U.S.
Department of Health and Human Services announced plans for a national
network of tobacco cessation quitlines to provide all smokers in the
United States access to the support and latest information to help them
quit. To provide the highest level of assistance to smokers across the
country who wants to quit, NCI established a new toll-free telephone
number (1-800-QUIT-NOW) on November 8, 2004. The aim of the National
Network of Tobacco Cessation Quitlines (NNTCQ) initiative (the
Initiative) is to strengthen service delivery; provide a mechanism for
integration and implementation of state, regional, and national
campaigns; and increase healthcare utilization by minority and
medically underserved populations. NCI, CDC, and other state, private
industry, and partner organizations (the North American Quitline
Consortium) have created the infrastructure and a coordinated mechanism
to offer cessation services to the American public. The Initiative
seeks to enhance existing state-managed quitlines and to encourage the
establishment of quitlines in states without them. It is expected that
successful implementation of the Initiative will foster partnerships
across state quitlines for technology transfer, sharing of effective
practices, and understanding patterns of use and reach to special
populations, thereby ensuring a sustained level of effectiveness over
time. The goal of this evaluation is to monitor the implementation of
the Initiative, assess its impact on key stakeholders, and examine its
implications for public health. To that end, this study will conduct a
series of in-depth key informant telephone interviews and selected site
visits with state tobacco control officers, quitline administrators and
counseling staff. Representatives of organizations and individuals that
partner with quitlines, such as community health organizations or
health care providers, will also be interviewed. The findings will
provide valuable information concerning the development and
implementation of the NNTQC initiative as a potential model for
Federal-State partnerships, the impact on building and enhancing state
quitline capacity, and implications for the state tobacco control
community.
The annual reporting burden is presented in exhibit 1, below.
Frequency of Response: One occasion.
Affected Public: State agencies, businesses or other for-profit,
non-profit associations.
Type of Respondents: Federal and state employees, health services
providers, administrators and researchers.
The annual reporting burden is as follows:
Estimated Number of Respondents: 228.
Estimated Number of Responses per Respondent: 1.
[[Page 51627]]
Average Burden Hours per Response: .7445.
Estimated Total Annual Burden Hours Requested: 169.75.
The annualized cost to respondents is $7,129.50.
There are no Capital Costs to report. There are no Operating or
Maintenance Costs to report.
----------------------------------------------------------------------------------------------------------------
Estimated Estimated
Estimated number of Average total annual
Type of respondents number of responses per burden hours burden hours
respondents respondent per response requested
----------------------------------------------------------------------------------------------------------------
State Tobacco Control Manager................... 51 1 1.00 51.00
State Quitline Administrator.................... 51 1 1.00 51.00
State Quitline Service Provider................. 19 1 .75 14.25
State Quitline Partner.......................... 102 1 .50 51.00
NAQC Representative............................. 5 1 .50 2.50
---------------------------------------------------------------
Total....................................... 228 .............. .............. 169.75
----------------------------------------------------------------------------------------------------------------
Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (1) Whether the proposed collection of information is
necessary for the proper performance of the function of the agency,
including whether the information will have practical utility; (2) the
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) ways to minimize
the burden of the collection of information on those who are to
respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, New Executive Office Building, Room 10235, Washington, DC
20503, Attention: Desk Officer for NIH. To request more information on
the proposed project or to obtain a copy of the data collection plans
and instruments, contact Candace Deaton, M.P.A., Project Officer,
National Cancer Institute, Cancer Information Service, 6116 Executive
Blvd., Suite 3056A, Room 3028, Rockville, MD 20892 or call non-toll-
free number 301-594-9072 or e-mail your request, including your address
to: deatonc@mail.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30-days
of the date of this publication.
Dated: August 21, 2006.
Rachelle Ragland Greene,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. E6-14354 Filed 8-29-06; 8:45 am]
BILLING CODE 4101-01-P
